ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 206 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,000 | 0.0% | 150 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $14,000 | -17.6% | 150 | 0.0% | 0.01% | -28.6% |
| Q1 2021 | $17,000 | -19.0% | 150 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $21,000 | -16.0% | 150 | -50.0% | 0.01% | -30.8% |
| Q3 2020 | $25,000 | +8.7% | 300 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $23,000 | +76.9% | 300 | 0.0% | 0.01% | -18.8% |
| Q1 2020 | $13,000 | 0.0% | 300 | 0.0% | 0.02% | +77.8% |
| Q3 2019 | $13,000 | -31.6% | 300 | 0.0% | 0.01% | -30.8% |
| Q2 2019 | $19,000 | -9.5% | 300 | 0.0% | 0.01% | -13.3% |
| Q1 2019 | $21,000 | – | 300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |